Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-02

Clinical Trial Update: An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing patient satisfaction with A-101 topical solution for seborrheic keratoses has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • A-101 Topical Solution

Snippet

Sponsor: Aclaris Therapeutics, Inc. | Conditions: Seborrheic Keratosis | Phase 4 | Status: COMPLETED | Results posted: 2019-10-02